|

Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).

RECRUITINGPhase 2Sponsored by Stanford University
Actively Recruiting
PhasePhase 2
SponsorStanford University
Started2025-06-03
Est. completion2028-06
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT07022470

Summary

This is a prospective non-randomized clinical trial to evaluate the feasibility of 3 fraction versus a standard 4 fraction high dose rate brachytherapy regimen in patients with locally advanced cervical cancer.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Histologically documented malignancy of the cervix and planned to receive brachytherapy as part of definitive treatment.
* ECOG performance status of 0-2
* Age ≥ 18 years old.
* Ability to understand and the willingness to provide written informed consent.

Exclusion Criteria:

* Contraindication to receiving radiotherapy as determined by treating radiation oncologist.
* Contraindication to receiving MRI.
* Prior radiation to the pelvis \> 3 months ago
* Age \< 18 years old.
* Pregnant or breast-feeding

Conditions2

CancerCervical Cancers

Locations1 site

Stanford University
Palo Alto, California, 94304
Alyssa Yauger650-498-5271ayauger@stanford.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.